Takeda Pharmaceutical Co Ltd SEC filings TKPHF
Takeda Pharmaceutical Co Ltd has 710 filings in SEC EDGAR's recent list, going back to Mar 5, 2007. Its latest annual report, Form 20-F, was filed on Jun 17, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 29, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| IRANNOTICE | Filing | Jun 17, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 22, 2026 | — |
| N-PX | Filing | Aug 21, 2025 | Aug 20, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 12, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | Apr 25, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 15, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 13, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | May 17, 2021 | — |
| CERT | Nyse certification filing | Jul 9, 2020 | — |
| 8-A12B | Form 8-a12b | Jul 9, 2020 | — |
| EFFECT | Filing | Mar 2, 2020 | — |
| EFFECT | Filing | Nov 14, 2019 | — |
| CORRESP | Letter to the SEC | Nov 12, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2019 | — |
| CT ORDER | Filing | Dec 26, 2018 | — |
| SEC STAFF ACTION | Filing | Dec 21, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2018 | — |
| CERT | Nyse certification filing- takeda pharmaceutical co ltd | Dec 18, 2018 | — |
| CORRESP | Letter to the SEC | Dec 18, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2018 | — |
| CORRESP | Letter to the SEC | Dec 17, 2018 | — |
| 20FR12B/A | 20fr12b/a no.1 | Dec 17, 2018 | — |
| CORRESP | Letter to the SEC | Dec 6, 2018 | — |
| CORRESP | Letter to the SEC | Dec 6, 2018 | — |
| 20FR12B | Filing | Dec 6, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2018 | — |
| DRSLTR | Filing | Nov 16, 2018 | — |
| DRS/A | Filing | Nov 16, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 5, 2018 | — |
| DRS | Filing | Sep 11, 2018 | — |
| SC TO-T/A | Amendment no. 9 to schedule to | Jul 31, 2018 | — |
| SC TO-T/A | Amendment no. 8 to schedule to | Jul 26, 2018 | — |
| SC TO-T/A | Amendment no. 7 to schedule to | Jul 6, 2018 | — |
| SC TO-T/A | Amendment no. 6 to schedule to | Jul 3, 2018 | — |
| SC TO-T/A | Amendment no. 5 to schedule to | Jun 6, 2018 | — |
| SC TO-T/A | Amendment no. 4 to schedule to | May 31, 2018 | — |
| SC TO-T/A | Amendment no. 3 to schedule to | May 23, 2018 | — |
| SC TO-T/A | Amendment no. 2 to schedule to | May 18, 2018 | — |
| SC TO-T/A | Amendment no. 1 to schedule to | May 11, 2018 | — |
| SC TO-T | Filing | Apr 30, 2018 | — |
| SC TO-C | Filing | Apr 25, 2018 | — |
| SC TO-C | Filing | Mar 23, 2018 | — |
| SC TO-C | Filing | Feb 13, 2018 | — |
| SC TO-C | Filing | Feb 1, 2018 | — |
| SC TO-C | Filing | Jan 26, 2018 | — |
| SC TO-C | Filing | Jan 9, 2018 | — |
| SC TO-C | Filing | Jan 5, 2018 | — |
| SC TO-C | Filing | Jan 5, 2018 | — |
| SC TO-T/A | Amendment no. 5 to sc to-t | Feb 16, 2017 | — |
| SC TO-T/A | Amendment no. 4 to sc to-t | Feb 8, 2017 | — |
| SC TO-T/A | Amendment no. 3 to sc to-t | Feb 2, 2017 | — |
| SC TO-T/A | Amendment no. 2 to sc to-t | Jan 30, 2017 | — |
| SC TO-T/A | Filing | Jan 24, 2017 | — |
| SC TO-T | Filing | Jan 19, 2017 | — |
| SC TO-C | Filing | Jan 11, 2017 | — |
| SC TO-C | Filing | Jan 10, 2017 | — |
| SC TO-C | Filing | Jan 9, 2017 | — |
| EFFECT | Filing | May 10, 2010 | — |
| SUPPL | Auto-generated paper document | Sep 26, 2008 | — |
| SUPPL | Auto-generated paper document | May 13, 2008 | — |
| SUPPL | Auto-generated paper document | Mar 14, 2008 | — |
| SUPPL | Auto-generated paper document | Dec 28, 2007 | — |
| SUPPL | Auto-generated paper document | Sep 27, 2007 | — |
| SUPPL | Auto-generated paper document | Mar 5, 2007 | — |
| 12G3-2B | Auto-generated paper document | Mar 5, 2007 | — |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TAK (NYSE), TKPHF (OTC)
- Headquarters
- Tokyo, Japan
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1395064
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.